Androgen receptor coregulators NOCR1, TIF2, and ARA70 may account for the hydroxyflutamide insensitivity of prostate cancer cells.

MLA

Wang, Y., et al. “Androgen Receptor Coregulators NOCR1, TIF2, and ARA70 May Account for the Hydroxyflutamide Insensitivity of Prostate Cancer Cells.” Irish Journal of Medical Science, vol. 180, no. 4, Dec. 2011, pp. 865–72. EBSCOhost, https://doi.org/10.1007/s11845-011-0714-4.

APA

Wang, Y., Li, J.-Q., Shao, C., Shi, C.-H., Liu, F., Yang, Z.-Y., Qiu, J.-X., Li, Y.-M., Fu, Q., Zhang, W., Xue, W., Lei, Y.-H., Gao, J.-Y., Wang, J.-Y., Gao, X.-P., Yuan, J.-L., Bao, T.-Y., & Zhang, Y.-T. (2011). Androgen receptor coregulators NOCR1, TIF2, and ARA70 may account for the hydroxyflutamide insensitivity of prostate cancer cells. Irish Journal of Medical Science, 180(4), 865–872. https://doi.org/10.1007/s11845-011-0714-4

Chicago

Wang, Y., J.-Q. Li, C. Shao, C.-H. Shi, F. Liu, Z.-Y. Yang, J.-X. Qiu, et al. 2011. “Androgen Receptor Coregulators NOCR1, TIF2, and ARA70 May Account for the Hydroxyflutamide Insensitivity of Prostate Cancer Cells.” Irish Journal of Medical Science 180 (4): 865–72. doi:10.1007/s11845-011-0714-4.